Net Cash Provided by (Used in) Operating Activities |
-15.3M |
USD |
+74% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
40.7M |
USD |
+46% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
25.4M |
USD |
|
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
146M |
USD |
+8.83% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Valuation Allowance |
383K |
USD |
-71.1% |
Q4 2024 |
FY 2024 |
Deferred Income Tax Expense (Benefit) |
2.38M |
USD |
-25.9% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
1.82M |
USD |
+45.6% |
Q4 2024 |
FY 2024 |
Current Income Tax Expense (Benefit) |
29K |
USD |
|
Q4 2024 |
FY 2024 |
Preferred Stock, Shares Authorized |
50M |
shares |
0% |
Q4 2024 |
FY 2024 |
Additional Paid in Capital |
1.03B |
USD |
+21.1% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
1.48M |
USD |
+76.6% |
Q4 2024 |
FY 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2024 |
FY 2024 |